Mahi Lakshmi Ashwath

Dr. Mahi Lakshmi Ashwath


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 June 2021 in Heart Failure Reviews
Verified
Journal Article
Open access
PDF file
CICorina Iorgoveanu
Corina Iorgoveanu
AZAhmed Zaghloul
Ahmed Zaghloul
Mahi Lakshmi AshwathMahi Lakshmi Ashwath
Mahi Lakshmi Ashwath
Peripartum cardiomyopathy is a form of idiopathic systolic heart failure which occurs during the end of pregnancy or the early post-partum in the absence of an identifiable etiology. The exact pathogenesis remains unknown, and the incidence is higher in African ancestry, multiparous and hypertensive women, or older maternal age. Delay in diagnosis is common, mainly because symptoms of heart failure mimic those of normal pregnancy. Echocardiography showing decreased myocardial function is at the center of the diagnosis. Management relies on the general guidelines of management of other forms of non-ischemic cardiomyopathy; however, special attention should be paid when choosing medications to ensure fetal safety. Outcomes can be variable and can range from complete recovery to persistent heart failure requiring transplant or even death. High rates of relapse with subsequent pregnancies can occur, especially with incomplete myocardial recovery. Additional research about the etiology, experimental drugs, prognosis, and duration of treatment after recovery are needed.

10 February 2023 in Current Problems in Cardiology
Verified
Journal Article
Closed access
AEAron Z. Evans
Aron Z. Evans
MAMehul Adhaduk
Mehul Adhaduk
AJAhmad R. Jabri
Ahmad R. Jabri
Mahi Lakshmi AshwathMahi Lakshmi Ashwath
Mahi Lakshmi Ashwath

Verified
Journal Article
Open access
PDF file
MCMayuresh Chaudhari
Mayuresh Chaudhari
Mahi Lakshmi AshwathMahi Lakshmi Ashwath
Mahi Lakshmi Ashwath
Heart failure (HF) is a complex clinical syndrome that results from any structural or functional impairment of ventricular filling or ejection of blood. The etiology of heart failure is multifactorial, encompassing ischemic heart disease, hypertension, valvular disorders, cardiomyopathies, and metabolic and infiltrative diseases. Despite advances in pharmacologic and device-based therapies, heart failure continues to carry a substantial burden of morbidity, mortality, and healthcare utilization. With the advancement and increased accessibility of cardiac imaging modalities, the diagnostic accuracy for identifying the underlying etiologies of nonischemic cardiomyopathy has significantly improved, allowing for more precise classification and tailored management strategies. This review aims to provide a comprehensive analysis of the current understanding of heart failure, encompassing epidemiology, etiological factors, with a specific focus on diagnostic imaging modalities including the role of echocardiography and strain imaging, cardiac magnetic resonance imaging (CMR), cardiac computed tomography (CT), and nuclear positron emission tomography (PET) imaging and recent advances in the diagnosis and management of heart failure.

9 February 2021 in HeartRhythm Case Reports
Verified
Journal Article
Open access
PDF file
EAEmmanuel Akintoye
Emmanuel Akintoye
Mahi Lakshmi AshwathMahi Lakshmi Ashwath
Mahi Lakshmi Ashwath

25 December 2025 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
MCMayuresh Chaudhari
Mayuresh Chaudhari
Mahi Lakshmi AshwathMahi Lakshmi Ashwath
Mahi Lakshmi Ashwath
Cardiac amyloidosis is an underdiagnosed cause of heart failure characterized by extracellular deposition of misfolded proteins. Advances in non-invasive imaging, including echocardiography, cardiac magnetic resonance imaging (CMR), and radionuclide imaging, have significantly enhanced the diagnostic accuracy and monitoring of cardiac amyloidosis. This review explores the role of each modality, their individual strengths, and current consensus recommendations. Emphasis is placed on the integration of multimodal imaging to guide diagnosis, prognosis, and therapeutic decisions in both AL and ATTR amyloidosis.

21 December 2023 in European Heart Journal - Case Reports
Verified
Journal Article
Open access
PDF file
GAGrace Grace Alexander
Grace Grace Alexander
Mahi Lakshmi AshwathMahi Lakshmi Ashwath
Mahi Lakshmi Ashwath
Background: Cardiac pseudoaneurysms are a potentially life-threatening pathology with a variety of non-specific clinical manifestations. This case series uniquely shares a collection of rare pathologies with differing preceding risk factors and presentations, with an emphasis on the utility of multi-modality imaging in diagnosis and management. Case summary: We present three cases of cardiac pseudoaneurysms. Case 1 is a 27-year-old woman with delayed presentation of a traumatic left ventricular pseudoaneurysm (LVP). Case 2 is a 73-year-old man with post-myocardial infarction LVP. Case 3 is a 38-year-old man with left ventricular outflow tract pseudoaneurysm after aortic valve replacement. Discussion: Cardiac pseudoaneurysms are rare and important to diagnose in a timely manner. Advances in non-invasive imaging modalities have improved our ability to distinguish pseudoaneurysms from other pathologies, leading to more timely management.